AI Article Synopsis
Article Abstract
Most of the Alzheimer's disease (AD)-linked mutations in amyloid precursor protein (APP), which cause abnormal production of beta-amyloid (Abeta), are localized at the major beta-secretase-and gamma-secretase cleavage sites. In this study, using an APP-knockout mouse neuronal cell line, our data demonstrated that at the P2-P1 positions of the epsilon-cleavage site at Abeta49 and the zeta-cleavage site at Abeta46, aromatic amino acids caused a strong reduction in total Abeta. On the other hand, residues with a long side chain caused a decrease in Abeta(40) and a concomitant increase in Abeta(42) and Abeta(38). These findings indicate that the structures of the substituting residues at these key positions strongly determine the efficiency and preference of gamma-secretase-mediated APP processing, which determines the ratio of different secreted Abeta species, a crucial factor in the disease development. Our findings provide new insight into the mechanisms of gamma-secretase-mediated APP processing and, specifically, into why most AD-linked APP mutations are localized at major gamma-secretase cleavage sites. This information may contribute to the development of methods of prevention and treatment of Alzheimer's disease aimed at modulating gamma-secretase activity.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520095 | PMC |
| http://dx.doi.org/10.1016/j.nbd.2009.08.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Observational study of intracranial compliance analysis in neurologically healthy pediatric patients using a non-invasive device.
Sci Rep
August 2024
Department of Neurology, Hospital Pequeno Príncipe, Curitiba, PR, Brazil.
Article Synopsis
- The study looked at how intracranial pressure (ICP) behaves in healthy kids to help understand brain conditions.
- Researchers used a special device to measure ICP while kids were lying down and sitting up.
- The kids were mostly satisfied with the device, saying it didn’t bother them and rated their comfort very high.
Characterization of intracranial compliance in healthy subjects using a noninvasive method - results from a multicenter prospective observational study.
J Clin Monit Comput
December 2024
Health Sciences Postgraduation Program, Federal University of Amazonas, General Rodrigo Octavio Jordão Ramos Avenue, 1200, Manaus, Amazonas, 69067-005, Brazil.
Article Synopsis
- An FDA-approved non-invasive intracranial pressure (ICP) monitoring system was used to study variations in ICP waveforms across different age groups to assess intracranial compliance in healthy volunteers.
- The study involved 188 healthy participants aged 9 to 74, measuring the non-invasive ICP waveform, P2/P1 ratio, and time-to-peak over a 5-minute period while lying down.
- Results showed that men had lower P2/P1 ratios and time-to-peak than women, with both measures increasing with age, highlighting the need for more extensive research to establish reference values for health assessments.
ICP wave morphology as a screening test to exclude intracranial hypertension in brain-injured patients: a non-invasive perspective.
J Clin Monit Comput
August 2024
Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, Brazil.
Intracranial hypertension (IH) is a life-threating condition especially for the brain injured patient. In such cases, an external ventricular drain (EVD) or an intraparenchymal bolt are the conventional gold standard for intracranial pressure (ICPi) monitoring. However, these techniques have several limitations.
View Article and Find Full Text PDFComparison of Noninvasive Measurements of Intracranial with Tap Test Results in Patients with Idiopathic Normal Pressure Hydrocephalus.
Neuropsychiatr Dis Treat
May 2023
Brain Hydrodynamics Group, Department of Neurosurgery, Hospital das Clínicas, University of São Paulo, São Paulo City, São Paulo State, Brazil.
Background: Normal pressure hydrocephalus is a disease directly related to the change in intracranial compliance and consequent repercussions in the brain parenchyma. Invasive monitoring of such parameters proves to be reliable especially for prognosis in neurocritical patients; however, it is not applicable in an outpatient service setting. The present study describes the comparison between the tap test results and the parameters obtained with a non-invasive sensor for monitoring intracranial compliance in patients with suspected NPH.
View Article and Find Full Text PDFIntracranial compliance in type 2 diabetes mellitus and its relationship with the cardiovascular autonomic nervous control.
Braz J Med Biol Res
September 2022
Laboratório de Fisioterapia Cardiovascular, Departamento de Fisioterapia, Universidade Federal de São Carlos, São Carlos, SP, Brasil.
The intracranial compliance in type 2 diabetes mellitus (T2DM) patients and the association with cardiovascular autonomic control have not been fully elucidated. The aim of this study was to assess intracranial compliance using the noninvasive intracranial pressure (niICP) and the monitoring of waveform peaks (P1, P2, and P3) and the relationship with cardiovascular autonomic control in T2DM patients. Thirty-two men aged 40-60 years without cardiovascular autonomic neuropathy (CAN) were studied: T2DMG (n=16) and control group CG (n=16).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!